Susquehanna International Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.5M Sell
64,600
-67,800
-51% -$16.9M ﹤0.01% 2607
2025
Q4
$31.9M Buy
132,400
+41,700
+46% +$10.7M ﹤0.01% 1761
2025
Q3
$24.8M Sell
90,700
-37,500
-29% -$10.2M ﹤0.01% 1981
2025
Q2
$33.1M Buy
128,200
+79,200
+162% +$18.9M ﹤0.01% 1513
2025
Q1
$11M Sell
49,000
-27,500
-36% -$6.42M ﹤0.01% 2411
2024
Q4
$17.5M Sell
76,500
-52,900
-41% -$12.7M ﹤0.01% 1987
2024
Q3
$31.6M Buy
129,400
+24,600
+23% +$5.5M 0.01% 1429
2024
Q2
$20.1M Sell
104,800
-84,000
-44% -$17M ﹤0.01% 1725
2024
Q1
$37.4M Buy
188,800
+68,500
+57% +$12.6M 0.01% 1235
2023
Q4
$20.7M Buy
120,300
+12,800
+12% +$1.97M ﹤0.01% 1780
2023
Q3
$15.9M Sell
107,500
-60,200
-36% -$10.9M ﹤0.01% 2007
2023
Q2
$36.6M Buy
167,700
+122,300
+269% +$27.3M 0.01% 1207
2023
Q1
$9.94M Buy
45,400
+10,200
+29% +$2.21M ﹤0.01% 2460
2022
Q4
$7.33M Sell
35,200
-51,000
-59% -$11.2M ﹤0.01% 2691
2022
Q3
$18.8M Buy
86,200
+68,700
+393% +$15.6M ﹤0.01% 1479
2022
Q2
$3.67M Sell
17,500
-6,600
-27% -$1.41M ﹤0.01% 3722
2022
Q1
$5.84M Buy
24,100
+4,000
+20% +$968K ﹤0.01% 3374
2021
Q4
$5.24M Sell
20,100
-14,900
-43% -$3.87M ﹤0.01% 3667
2021
Q3
$9.22M Sell
35,000
-34,600
-50% -$9.46M ﹤0.01% 2982
2021
Q2
$17.2M Buy
69,600
+36,200
+108% +$7.61M ﹤0.01% 2230
2021
Q1
$6.48M Sell
33,400
-30,000
-47% -$6.02M ﹤0.01% 3443
2020
Q4
$13.5M Buy
63,400
+2,700
+4% +$538K ﹤0.01% 2146
2020
Q3
$10.4M Buy
60,700
+16,700
+38% +$3.08M ﹤0.01% 2125
2020
Q2
$8.45M Sell
44,000
-10,900
-20% -$1.78M ﹤0.01% 2345
2020
Q1
$8.09M Sell
54,900
-98,000
-64% -$15.6M ﹤0.01% 1986
2019
Q4
$23.7M Buy
152,900
+60,400
+65% +$8.71M 0.01% 1270
2019
Q3
$12.5M Buy
92,500
+32,200
+53% +$4.22M ﹤0.01% 1752
2019
Q2
$7.36M Sell
60,300
-29,900
-33% -$3.31M ﹤0.01% 2237
2019
Q1
$9.38M Buy
90,200
+64,900
+257% +$6.7M ﹤0.01% 1800
2018
Q4
$2.88M Buy
25,300
+15,800
+166% +$1.69M ﹤0.01% 3003
2018
Q3
$1.1M Sell
9,500
-4,300
-31% -$471K ﹤0.01% 5049
2018
Q2
$1.43M Sell
13,800
-26,600
-66% -$2.69M ﹤0.01% 4639
2018
Q1
$3.98M Sell
40,400
-1,800
-4% -$170K ﹤0.01% 2827
2017
Q4
$3.57M Buy
42,200
+25,300
+150% +$2.09M ﹤0.01% 2961
2017
Q3
$1.3M Buy
16,900
+3,000
+22% +$229K ﹤0.01% 4762
2017
Q2
$1.08M Sell
13,900
-8,500
-38% -$608K ﹤0.01% 5093
2017
Q1
$1.61M Sell
22,400
-40,500
-64% -$2.8M ﹤0.01% 4122
2016
Q4
$3.9M Buy
62,900
+41,900
+200% +$2.57M ﹤0.01% 2823
2016
Q3
$1.36M Buy
21,000
+8,700
+71% +$579K ﹤0.01% 4224
2016
Q2
$778K Sell
12,300
-24,900
-67% -$1.47M ﹤0.01% 5351
2016
Q1
$2.15M Buy
37,200
+19,000
+104% +$1.08M ﹤0.01% 3632
2015
Q4
$977K Sell
18,200
-4,200
-19% -$237K ﹤0.01% 5443
2015
Q3
$1.14M Buy
22,400
+6,700
+43% +$361K ﹤0.01% 5448
2015
Q2
$885K Sell
15,700
-23,100
-60% -$1.46M ﹤0.01% 6470
2015
Q1
$2.79M Sell
38,800
-36,400
-48% -$2.36M ﹤0.01% 3688
2014
Q4
$4.22M Sell
75,200
-24,900
-25% -$1.3M ﹤0.01% 3133
2014
Q3
$4.93M Buy
100,100
+60,200
+151% +$3.07M ﹤0.01% 3047
2014
Q2
$2.02M Sell
39,900
-192,200
-83% -$9.53M ﹤0.01% 4637
2014
Q1
$10.4M Sell
232,100
-12,300
-5% -$552K ﹤0.01% 1971
2013
Q4
$11.5M Sell
244,400
-10,400
-4% -$526K 0.01% 1902
2013
Q3
$13.5M Buy
254,800
+93,200
+58% +$4.52M 0.01% 1575
2013
Q2
$7.29M Buy
+161,600
New +$7.67M ﹤0.01% 2172

Other funds holding RMD

Susquehanna International Group's RMD Position: Q1 2026 in Review

Susquehanna International Group reduced its ResMed (RMD) stake by 11% in Q1 2026, selling an estimated $1.21M and leaving 38,172 shares worth $8.57M. The position accounts for ﹤0.01% of the portfolio, ranked #3344.

Susquehanna International Group first reported a position in RMD in Q2 2013 and has held it in 47 quarters since. The position peaked at $32.5M in Q1 2023. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Susquehanna International Group held 38,172 shares of ResMed worth $8.57M as of Q1 2026.
  • Susquehanna International Group sold 4,837 ResMed shares in Q1 2026, an estimated $1.21M.
  • ResMed made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3344 holding.
  • Susquehanna International Group first reported a position in ResMed in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's ResMed position peaked at $32.5M in Q1 2023.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.